generic and innovative drugs market in cis countries 2013

Development forecasts for 2013-2015

Generic and innovative drugs market in CIS countries 2013 Russia, Ukraine and Kazakhstan

2

+48 12 618 90 30

[email protected]

Which generic/innovative drugs post the highest sales in this region?

How large are these market segments in Russia? Ukraine? Kazakhstan?

Which recent regulatory adjustments have altered market conditions?

Which countries will experience the quickest rates of growth in the generic/innovative

drug sector between 2013-2015?

How do consumers and physicians view generic/innovative drugs in CIS countries?

How are the prices of both reimbursed and non-reimbursed generic/innovative drugs

regulated in CIS countries?

Which companies manufacture the greatest quantities of generic and innovative drugs

within the CIS region?

Generic and innovative drugs market in CIS countries 2013 - Russia, Ukraine and Kazakhstan Development forecasts for 2013 -2015

Click to buy

Language:

Date of publication:

Delivery:

Price from:

English

Q2

pdf

2000€

Find out…

http://www.pmrpublications.com/product/Generic-and-innovative-drugs-market-in-CIS-countries-2013

+48 12 618 90 30

[email protected]

3 Generic and innovative drugs market in CIS countries 2013 - Russia, Ukraine and Kazakhstan Development forecasts for 2013-2015

http://www.pmrpublications.com/product/Generic-and-innovative-drugs-market-in-CIS-countries-2013 Click to buy

Informational highlights

Regulations in each country that govern pricing and reimbursement

Price mark ups for applicable medicines

Reimbursement structures in each of the CIS countries

Analysis of changing drug reimbursement lists

Impact of reimbursement policy changes on these markets

Periods of data exclusivity and patent expirations

Innovative and generic medicines generating the highest sales

4

+48 12 618 90 30

[email protected]

In-depth market development

forecasts for

the period 2013-2015 – for

each segment in each country.

Forward looking analysis of

trends and events and their

roles in market growth

in the years to come.

Comparative analysis of vital

data and current market

conditions in Russia, Ukraine

and Kazakhstan based on

industry intelligence obtained

from a wide range of sources

and assembled into one

resource.


Click to buy

Comparative analysis Market forecasts Profiles of the most prolific

companies


Major advantages

The report also features

informative profiles of the

leading manufacturers of

generic and innovative

medicines in CIS countries.

5

+48 12 618 90 30

[email protected]

Assembling a diverse product portfolio

Setup of operations in these market segments

Keeping current with changing drug lists

Comparing the regulatory frameworks of CIS countries

Assessing the possibilities for growth in these segments

Compiling forecasts for market conditions.

Companies engaged in the production and

distribution of generic/innovative drugs

Businesses building a strategy for entry into this

market

Financial service providers

Pharma-related industry

Research, academic and governmental entities.


Click to buy

When to use it? Who uses it?


6

+48 12 618 90 30

[email protected]

Russia’s Pharma 2020

programme and its regulations

on foreign generic/innovative

drug producers aimed at

strengthening the domestic

pharmaceutical industry.

Progress of the Ukrainian

reimbursement structure,

initiated in 2012.


Click to buy

Ukraine Russia Kazakhstan


Learn more about specific market issues

Progress on the integration of

Good Manufacturing Practice

in Kazakhstan.

7

Contact us to learn more about this report Request a customised research or advisory assistance

+48 12 618 90 30

[email protected]

+48 12 618 90 08

[email protected]



Click here to buy this report

8

+48 12 618 90 30

[email protected]

Why do business professionals trust us?

As a London-based company,

with operations abroad, we

looked for the best-in-class

Market Intelligence supplier.

PMR brought us quality reports

that improved our CEE market

knowledge and understanding.

We consider PMR a competent

and professional company. PMR

analysts understand our needs

clearly and their services have

fully met our expectations.

I strongly recommend the

company as a reliable partner in

providing economic information

and market analysis.

We can now recommend

PMR as professional and

reliable partner in undertaking

research and market analysis, as

well as source of business

publications. We intend to

continue collaboration with

PMR in the future.

Click to buy http://www.pmrpublications.com/product/Generic-and-innovative-drugs-market-in-CIS-countries-2013

9

+48 12 618 90 30

[email protected]

PMR's expertise

Clients' benefits

Business consulting

Market research

Data analysis & forecasting

Market intelligence reports & services

Increasing revenues

Optimising costs

Entering new markets

Monitoring markets

Click to buy http://www.pmrpublications.com/product/Generic-and-innovative-drugs-market-in-CIS-countries-2013

What is PMR unique business offer?

10

tel.: +48 12 618 90 30

fax: +48 12 618 90 08

e-mail: [email protected]

www.pmrpublications.com

www.pmrconsulting.com

www.research-pmr.com

Behind the scenes

tailored research and consulting projects annually

In-house professionals

off-the-shelf market reports per year

online information portals and pdf periodicals

Central and Eastern Europe countries analysed

PMR is established 1995

200

100

70

30

25